Robert B.

Robert B. serves as the Director of Global Regulatory Affairs CMC at BioNTech SE since January 2023, focusing on mRNA vaccines within the infectious disease portfolio. Prior experience includes roles such as Associate Director of CMC Regulatory Affairs at Reata Pharmaceuticals and GSK, where responsibilities involved managing regulatory strategy and submission activities for multiple biopharmaceuticals. Robert has also worked as a consultant in regulatory affairs at Halozyme Therapeutics and Takeda, and held significant positions at Merck, GSK, Adolor, McNeil Consumer Healthcare, and Research Pharmaceutical Services. Robert holds a Master's degree in Regulatory Affairs and Quality Assurance from Temple University School of Pharmacy and a Bachelor's degree in Geological Oceanography and Chemistry from Millersville University of Pennsylvania.